Reports
Sale
North America Aortic Stent Graft Market Size, Share, Growth: By Product: Abdominal Aortic Stent Grafts, Thoracic Aortic Stent Grafts; By End User: Hospitals, Ambulatory Surgical Centers, Others; Regional Analysis; Market Dynamics: Market Drivers and Constraints, SWOT Analysis, Porter’s Five Forces Analysis; Supplier Landscape; 2024-2032
North America Aortic Stent Graft Market Outlook
The North America aortic stent graft market size was valued at USD 3.1 billion in 2023. It is expected to grow at a CAGR of 5.8% during the forecast period of 2024-2032, driven by the growing geriatric population along with the advancements in stent graft materials and design in the region. It is estimated to reach a value of USD 5.2 billion by 2032.
Key Takeaways
- In the United States, ruptured abdominal aortic aneurysms are responsible for an estimated 15,000 deaths annually, ranking as the 13th leading cause of death in the region.
- In April 2023, Medtronic plc, declared positive results from a 10-year post-market ENGAGE registry for its Endurant stent graft system which provides endovascular aneurysm repair (EVAR) to treat the abdominal aortic aneurysm.
- In December 2023 , W. L. Gore & Associates, Inc. announced the first patient treatment with Gore ascending stent graft in the ARISE II study to treat pathologies involving the ascending aorta, marking an advancement in minimally invasive procedures.
An aortic stent graft is a tube consisting of fabric supported by a metal mesh and is commonly used to treat abdominal aortic aneurysms (AAAs) and thoracic aortic aneurysms (TAAs). The rise in the prevalence of aortic aneurysms, characterized by the ballooning and weakening of the blood vessel, is expected to drive the North America aortic stent graft market demand. Recent data suggests that ruptured abdominal aortic aneurysms are responsible for an estimated 15,000 deaths annually in the United States, ranking as the 13th leading cause of death in the region. This indicates the need for innovative aortic stent graft products to tackle the rising burden of the disease and the associated mortality.
The market is witnessing increased investment in research and development activities by the key market players in order to meet the growing demand for improved and safer aortic stent grafts. In April 2023, Medtronic plc, an American medical device company, announced positive results from a 10-year post-market ENGAGE registry for its Endurant stent graft system which provides endovascular aneurysm repair (EVAR) to treat abdominal aortic aneurysm. The data was presented at the 2023 Charing Cross Symposium in London, revealing 94.7% of cases reporting freedom from aneurysm-related mortality out of a pool of 400 patients. The presence of such real-world patient evidence is likely to boost the trust of patients and healthcare providers in the efficacy of aortic stent grafts, thereby fuelling North America aortic stent graft market growth.
In December 2023 , W. L. Gore & Associates, Inc., an American multinational material science company, announced the first patient treatment with Gore ascending stent graft to treat pathologies involving the ascending aorta. It was based on the results of ARISE II, a pivotal study by the United States Food and Drug Administration (FDA). The study marks an advancement in minimally invasive procedures by using endovascular repair rather than conventional open surgical repair. The development of such minimally invasive alternatives which can reduce recovery times as well as the risk of complications is likely to augment the North America aortic stent graft market size in the forecast period.
The market is also driven by the rising technological innovation in stent grafts, the increased accessibility to novel medical devices in healthcare settings, and the growing elderly population at a greater risk of developing aortic aneurysms. Moreover, the presence of an advanced infrastructure and heightened patient awareness in the region is expected to bolster the market growth in the forecast period.
North America Aortic Stent Graft Market Segmentation
“North America Aortic Stent Graft Market Report and Forecast 2024-2032” offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Product | Abdominal Aortic Stent Grafts, Thoracic Aortic Stent Grafts |
| End User | Hospitals, Ambulatory Surgical Centers, Others |
| Countries | United States of America, Canada |
North America Aortic Stent Graft Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Cook Medical, Inc.
- W.L. Gore & Associates
- MicroPort Scientific Corporation Inc.
- Medtronic Plc.
- Lombard Medical, Inc.
- Endologix, Inc.
- Terumo Corporation Inc.
- Cardinal Health Inc.
- Becton, Dickinson and Company
- Cryolife Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 North America Aortic Stent Graft Market Overview
3.1 North America Aortic Stent Graft Market Historical Value (2017-2023)
3.2 North America Aortic Stent Graft Market Forecast Value (2024-2032)
4 North America Aortic Stent Graft Market Landscape*
4.1 North America Aortic Stent Graft: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 North America Aortic Stent Graft: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Type
4.2.3 Analysis by Application
5 North America Aortic Stent Graft Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 North America Aortic Stent Graft Market Segmentation (2017-2032)
6.1 North America Aortic Stent Graft Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Abdominal Aortic Stent Grafts
6.1.3 Thoracic Aortic stent Grafts
6.2 North America Aortic Stent Graft Market (2017-2032) by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Ambulatory Surgical Centers
6.2.4 Others
6.3 North America Aortic Stent Graft Market (2017-2032) by Countries
6.3.1 Market Overview
6.3.2 United States of America
6.3.3 Canada
7 United States of Aortic Stent Graft Market (2017-2032)
7.1 United State of Aortic Stent Graft Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Abdominal Aortic Stent Grafts
7.1.3 Thoracic Aortic stent Grafts
7.2 United State of Aortic Stent Graft Market (2017-2032) by End User
7.2.1 Market Overview
7.2.2 Hospitals
7.2.3 Ambulatory Surgical Centers
7.2.4 Others
8 Canada Aortic Stent Graft Market (2017-2032)
8.1 Canada Aortic Stent Graft Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Abdominal Aortic Stent Grafts
8.1.3 Thoracic Aortic stent Grafts
8.2 North America Aortic Stent Graft Market (2017-2032) by End User
8.2.1 Market Overview
8.2.2 Hospitals
8.2.3 Ambulatory Surgical Centers
8.2.4 Others
9 Regulatory Framework
10 Patent Analysis
10.1 Analysis by Type of Patent
10.2 Analysis by Publication year
10.3 Analysis by Issuing Authority
10.4 Analysis by Patent Age
10.5 Analysis by CPC Analysis
10.6 Analysis by Patent Valuation
10.7 Analysis by Key Players
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Partnership and Collaborations Analysis
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Partnership
12.3 Analysis by Leading Players
12.4 Analysis by Geography
13 Supplier Landscape
13.1 Market Share by Top 5 Companies
13.2 Cook Medical, Inc.
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 W.l. Gore & Associates
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 MicroPort Scientific Corporation Inc.
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 Medtronic Plc.
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 Lombard Medical, Inc.
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 Endologix, INC.
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 Terumo Corporation Inc.
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 Cardinal Health Inc.
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 Becton, Dickinson and Company
13.10.1 Financial Analysis
13.10.2 Product Portfolio
13.10.3 Demographic Reach and Achievements
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
13.11 Cryolife Inc.
13.11.1 Financial Analysis
13.11.2 Product Portfolio
13.11.3 Demographic Reach and Achievements
13.11.4 Mergers and Acquisitions
13.11.5 Certifications
14 United States of America Cannula Market – Distribution Model (Additional Insight)
14.1 Overview
14.2 Potential Distributors
14.3 Key Parameters for Distribution Partner Assessment
15 Key Opinion Leaders (KOL) Insights (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
16.1 Very Small Companies
16.2 Small Companies
16.3 Mid-Sized Companies
16.4 Large Companies
16.5 Very Large Companies
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 3.1 billion in 2023 driven by the growing geriatric population along with the advancements in stent graft materials and design in the region.
The market is anticipated to grow at a CAGR of 5.8% during the forecast period of 2024-2032, and estimated to reach a value of USD 5.2 billion by 2032.
The growing demand for minimally invasive procedures and rising healthcare expenditure are fuelling the demand for the regional market.
One of the significant trends in the market is the increased number of clinical studies to evaluate aortic stent graft efficacy and safety profile. In April 2023, Medtronic plc, announced positive results for its Endurant stent graft system which provides endovascular aneurysm repair (EVAR) to treat abdominal aortic aneurysm.
Based on the product, the market is segmented into abdominal aortic stent grafts and thoracic aortic stent grafts.
Major end users of the market include hospitals, and ambulatory surgical centres, among others.
The market segmentation by countries includes the United States of America and Canada.
The key market players are Cook Medical, Inc., W.L. Gore & Associates, MicroPort Scientific Corporation Inc., Medtronic PLC, Lombard Medical, Inc., Endologix, Inc., Terumo Corporation Inc., Cardinal Health Inc., Becton, Dickinson and Company, and CryoLife Inc.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER